Literature DB >> 25234924

A systematic study on the influence of the main ingredients of an ivy leaves dry extract on the β2-adrenergic responsiveness of human airway smooth muscle cells.

Christian Greunke1, Anne Hage-Hülsmann1, Thomas Sorkalla1, Nelli Keksel1, Felix Häberlein1, Hanns Häberlein2.   

Abstract

The bronchospasmolytic and secretolytic effects of ivy leaves dry extracts can be explained by an increased β2-adrenergic responsiveness of the bronchi. Recently, it was shown that α-hederin inhibits the internalization of β2-adrenergic receptors (ß2AR) under stimulating conditions. α-Hederin pretreated alveolar type II cells and human airway smooth muscle cells revealed an increased ß2AR binding and an elevated intracellular cAMP level, respectively. In order to identify whether additional compounds also mediate an increased β2-adrenergic responsiveness, we examined the ingredients of an ivy leaves dry extract (EA 575) protocatechuic acid, neochlorogenic acid, chlorogenic acid, cryptochlorogenic acid, rutin, kaempferol-3-O-rutinoside, 3,4-, 3,5- and 4,5-dicaffeoylquinic acid, hederacoside B, and β-hederin. Within all the tested substances, only β-hederin inhibited the internalization of GFP-tagged ß2AR in stably transfected HEK293 cells. Using fluorescence correlation spectroscopy β-hederin (1 μM, 24 h) pretreated HASM cells showed a statistically significant increase in the ß2AR binding from 33.0 ± 8.9% to 44.1 ± 11.5% which was distributed with 36.0 ± 9.5% for τbound1 and 8.1 ± 2.6% for τbound2, respectively (n = 8, p < 0.05). The increased binding was selectively found for the receptor-ligand complex with unrestricted lateral mobility (τbound1 of 0.9 ± 0.1 ms, D1 = 9.1 ± 0.2 μm(2)/s, n = 8), whereas the binding of ß2AR with hindered lateral mobility (τbound2 of 64.2 ± 47.6 ms, D2 = 0.15 ± 0.02 μm(2)/s, n = 8) was not affected. Compared to control cells, a statistically significant increase of 17.5 ± 6.4% (n = 4, p < 0.05) and 24.2 ± 5.8% (n = 4, p < 0.001) in the cAMP formation was found for β-hederin pretreated HASM cells after stimulation with 10 μM of terbutaline and simultaneous stimulation with 10 μM terbutaline and 10 μM forskolin, respectively. Within this systematic study focusing on the influence of the ingredients of an ivy leaves dry extract on HASM cells it was possible to identify β-hederin as further component presumably responsible for the β2-mimetic effects.
Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Flavonoids; Ivy leaves dry extract; Phenolic acids; Saponins; β(2)-adrenergic receptor

Mesh:

Substances:

Year:  2014        PMID: 25234924     DOI: 10.1016/j.pupt.2014.09.002

Source DB:  PubMed          Journal:  Pulm Pharmacol Ther        ISSN: 1094-5539            Impact factor:   3.410


  5 in total

1.  Bioactive phenolics fraction of Hedera helix L. (Common Ivy Leaf) standardized extract ameliorates LPS-induced acute lung injury in the mouse model through the inhibition of proinflammatory cytokines and oxidative stress.

Authors:  Aya A Shokry; Riham A El-Shiekh; Gehan Kamel; Alaa F Bakr; Amer Ramadan
Journal:  Heliyon       Date:  2022-05-19

2.  The clinical efficacy of AG NPP709 (Synatura®) in patients with chronic bronchitis type stable chronic obstructive pulmonary disease.

Authors:  Eung Gu Lee; Chin Kook Rhee
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 2.895

3.  A rapid and sensitive liquid chromatography-tandem mass spectrometric method for the determination of hederasaponin B in rat plasma: Application to a pharmacokinetic study.

Authors:  Jiaxin Liu; Xueyan Yang; Lin Li; Qili Zhang; Zhaoyan Zhang; Xin Zhang; Yunli Zhao; Miao Yu; Zhiguo Yu
Journal:  Asian J Pharm Sci       Date:  2016-09-22       Impact factor: 6.598

4.  Ilex kaushue and Its Bioactive Component 3,5-Dicaffeoylquinic Acid Protected Mice from Lipopolysaccharide-Induced Acute Lung Injury.

Authors:  Yu-Li Chen; Tsong-Long Hwang; Huang-Ping Yu; Jia-You Fang; Kowit Yu Chong; Yao-Wen Chang; Chun-Yu Chen; Hsuan-Wu Yang; Wen-Yi Chang; Pei-Wen Hsieh
Journal:  Sci Rep       Date:  2016-09-29       Impact factor: 4.379

5.  Efficacy of two dosing schemes of a liquid containing ivy leaves dry extract EA 575 versus placebo in the treatment of acute bronchitis in adults.

Authors:  Axel Schaefer; Fanny Ludwig; Bruno M Giannetti; Michael Bulitta; Anja Wacker
Journal:  ERJ Open Res       Date:  2019-12-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.